Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
AIM ImmunoTech Inc. (AIMI) had Normalized Income after Taxes of $-3.73M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.02M |
|
$-3.71M |
|
$0.01M |
|
$0.01M |
|
$3.63M |
|
$-3.62M |
|
$-0.09M |
|
$-3.71M |
|
$-3.73M |
|
$-3.71M |
|
$-3.71M |
|
$-3.71M |
|
|
Normalized Income after Taxes |
$-3.73M |
$-3.62M |
|
$-3.16M |
|
70.33M |
|
70.33M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$2.58M |
|
$0.10M |
|
$3.66M |
|
$6.25M |
|
$9.77M |
|
-- |
|
$0.34M |
|
$10.11M |
|
$-3.86M |
|
$-6.12M |
|
$-3.86M |
|
72.29M |
|
| Cash Flow Statement Financials | |
$-2.36M |
|
$0.90M |
|
$0.66M |
|
$1.70M |
|
$0.90M |
|
$-0.80M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.26 |
|
-- |
|
-- |
|
-- |
|
-0.51 |
|
37.50% |
|
-22618.75% |
|
-22618.75% |
|
-- |
|
-23156.25% |
|
-23156.25% |
|
$-2.36M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.84 |
|
106.88 |
|
96.06% |
|
60.50% |
|
-59.30% |
|
96.06% |
|
$-0.05 |
|
$-0.03 |
|
$-0.03 |
|